Response to Office Action

KEYSTONE

Spark Therapeutics, Inc.

Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88338264
LAW OFFICE ASSIGNED LAW OFFICE 109
MARK SECTION
MARK http://uspto.report/TM/88338264/mark.png
LITERAL ELEMENT KEYSTONE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
ARGUMENT(S)
Please see the actual argument text attached within the Evidence section.
EVIDENCE SECTION
        EVIDENCE FILE NAME(S)
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Response_to_Office_Action-_KEYSTONE__88338264_.pdf
       CONVERTED PDF FILE(S)
       (12 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0002.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0005.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0006.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0007.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0008.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0011.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0012.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0013.JPG
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Exhibit_A-_KEYSTONE.pdf
       CONVERTED PDF FILE(S)
       (4 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0014.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0015.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0016.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0017.JPG
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Exhibit_B-_KEYSTONE.pdf
       CONVERTED PDF FILE(S)
       (7 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0018.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0019.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0020.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0021.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0022.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0023.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0024.JPG
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Exhibit_C-_KEYSTONE.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0025.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0026.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0027.JPG
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Exhibit_D-_KEYSTONE.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0028.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0029.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0030.JPG
       ORIGINAL PDF FILE evi_1-104129194195-20191124145140520601_._Exhibit_E-_KEYSTONE.pdf
       CONVERTED PDF FILE(S)
       (4 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0031.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0032.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0033.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0034.JPG
DESCRIPTION OF EVIDENCE FILE Response to Office Action dated May 29, 2019 and exhibits
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 042
DESCRIPTION
Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia
FILING BASIS Section 1(b)
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 042
TRACKED TEXT DESCRIPTION
Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia; Conducting clinical trials in the field of hemophilia; providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
FINAL DESCRIPTION
Conducting clinical trials in the field of hemophilia; providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
FILING BASIS Section 1(b)
ATTORNEY SECTION (current)
NAME Jamie B. Bischoff
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
INTERNAL ADDRESS BALLARD SPAHR LLP
STREET 1735 MARKET STREET, 51ST FLOOR
CITY PHILADELPHIA
STATE Pennsylvania
POSTAL CODE 19103-7599
COUNTRY US
PHONE 215-864-8207
FAX 215.864.8999
EMAIL bischoff@ballardspahr.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER 00305922
ATTORNEY SECTION (proposed)
NAME Jamie B. Bischoff
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
INTERNAL ADDRESS BALLARD SPAHR LLP
STREET 1735 MARKET STREET, 51ST FLOOR
CITY PHILADELPHIA
STATE Pennsylvania
POSTAL CODE 19103-7599
COUNTRY United States
PHONE 2156658500
FAX 215.864.8999
EMAIL tmdocketing@ballardspahr.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER 00305922
OTHER APPOINTED ATTORNEY all of the firm of Ballard Spahr LLP
CORRESPONDENCE SECTION (current)
NAME JAMIE B. BISCHOFF
INTERNAL ADDRESS BALLARD SPAHR LLP
STREET 1735 MARKET STREET, 51ST FLOOR
CITY PHILADELPHIA
STATE Pennsylvania
POSTAL CODE 19103-7599
COUNTRY US
PHONE 215-864-8207
FAX 215.864.8999
EMAIL bischoff@ballardspahr.com; phila_tmdocketing@ballardspahr.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER 00305922
CORRESPONDENCE SECTION (proposed)
NAME Jamie B. Bischoff
FIRM NAME Ballard Spahr LLP
INTERNAL ADDRESS 1735 Market Street, 51st Floor
STREET 1735 Market Street, 51st Floor
CITY Philadelphia
STATE Pennsylvania
POSTAL CODE 19103-7599
COUNTRY United States
PHONE 2156658500
FAX 215.864.8999
EMAIL tmdocketing@ballardspahr.com; curciot@ballardspahr.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER 00305922
SIGNATURE SECTION
RESPONSE SIGNATURE /tmc/
SIGNATORY'S NAME Tanya Marie Curcio
SIGNATORY'S POSITION Attorney, Ballard Spahr, New York bar member
SIGNATORY'S PHONE NUMBER 215-864-8864
DATE SIGNED 11/24/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Sun Nov 24 15:08:32 EST 2019
TEAS STAMP USPTO/ROA-XXX.XXX.XXX.XXX
-20191124150832143655-883
38264-70035f033da7e6b4d99
1cd937a3871e0549ad59952bf
d979b467a9fa76764729-N/A-
N/A-20191124145140520601



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 88338264 KEYSTONE(Standard Characters, see http://uspto.report/TM/88338264/mark.png) has been amended as follows:

ARGUMENT(S)
In response to the substantive refusal(s), please note the following:

Please see the actual argument text attached within the Evidence section.

EVIDENCE
Evidence in the nature of Response to Office Action dated May 29, 2019 and exhibits has been attached.
Original PDF file:
evi_1-104129194195-20191124145140520601_._Response_to_Office_Action-_KEYSTONE__88338264_.pdf
Converted PDF file(s) ( 12 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Evidence-8
Evidence-9
Evidence-10
Evidence-11
Evidence-12
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_A-_KEYSTONE.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_B-_KEYSTONE.pdf
Converted PDF file(s) ( 7 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_C-_KEYSTONE.pdf
Converted PDF file(s) ( 3 pages)
Evidence-1
Evidence-2
Evidence-3
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_D-_KEYSTONE.pdf
Converted PDF file(s) ( 3 pages)
Evidence-1
Evidence-2
Evidence-3
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_E-_KEYSTONE.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Proposed:
Tracked Text Description: Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia; Conducting clinical trials in the field of hemophilia; providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophiliaClass 042 for Conducting clinical trials in the field of hemophilia; providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

The applicant's current attorney information: Jamie B. Bischoff. Jamie B. Bischoff, is located at

      BALLARD SPAHR LLP
      1735 MARKET STREET, 51ST FLOOR
      PHILADELPHIA, Pennsylvania 19103-7599
      US
The docket/reference number is 00305922.

The phone number is 215-864-8207.

The fax number is 215.864.8999.

The email address is bischoff@ballardspahr.com

The applicants proposed attorney information: Jamie B. Bischoff. Other appointed attorneys are all of the firm of Ballard Spahr LLP. Jamie B. Bischoff, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      BALLARD SPAHR LLP
      1735 MARKET STREET, 51ST FLOOR
      PHILADELPHIA, Pennsylvania 19103-7599
      United States
The docket/reference number is 00305922.

The phone number is 2156658500.

The fax number is 215.864.8999.

The email address is tmdocketing@ballardspahr.com

Jamie B. Bischoff submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current correspondence information: JAMIE B. BISCHOFF. JAMIE B. BISCHOFF, is located at

      BALLARD SPAHR LLP
      1735 MARKET STREET, 51ST FLOOR
      PHILADELPHIA, Pennsylvania 19103-7599
      US
The docket/reference number is 00305922.

The phone number is 215-864-8207.

The fax number is 215.864.8999.

The email address is bischoff@ballardspahr.com; phila_tmdocketing@ballardspahr.com

The applicants proposed correspondence information: Jamie B. Bischoff. Jamie B. Bischoff of Ballard Spahr LLP, is located at

      1735 Market Street, 51st Floor
      1735 Market Street, 51st Floor
      Philadelphia, Pennsylvania 19103-7599
      United States
The docket/reference number is 00305922.

The phone number is 2156658500.

The fax number is 215.864.8999.

The email address is tmdocketing@ballardspahr.com; curciot@ballardspahr.com

SIGNATURE(S)
Response Signature
Signature: /tmc/     Date: 11/24/2019
Signatory's Name: Tanya Marie Curcio
Signatory's Position: Attorney, Ballard Spahr, New York bar member

Signatory's Phone Number: 215-864-8864

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    JAMIE B. BISCHOFF
   
   BALLARD SPAHR LLP
   1735 MARKET STREET, 51ST FLOOR
   PHILADELPHIA, Pennsylvania 19103-7599
Mailing Address:    Jamie B. Bischoff
   Ballard Spahr LLP
   1735 Market Street, 51st Floor
   1735 Market Street, 51st Floor
   Philadelphia, Pennsylvania 19103-7599
        
Serial Number: 88338264
Internet Transmission Date: Sun Nov 24 15:08:32 EST 2019
TEAS Stamp: USPTO/ROA-XXX.XXX.XXX.XXX-20191124150832
143655-88338264-70035f033da7e6b4d991cd93
7a3871e0549ad59952bfd979b467a9fa76764729
-N/A-N/A-20191124145140520601


Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed